ADAMTS6 and osteoporosis: Although laboratorial findings reported previously strongly suggested ADAM12, ADAM19, ADAM23, and ADAMTS6 were potential participants in bone metabolism, our two-sample MR estimates had great robustness to support no MR association between levels of these metallopeptidases and osteoporosis based on the results of various MR methods and sensitivity analyses.